• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3160 例经放射引导植入完全植入式中央静脉港系统的结果分析。

Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems.

机构信息

Department of Radiology, Charité University Hospital, Berlin, Germany.

出版信息

Eur Radiol. 2011 Jun;21(6):1224-32. doi: 10.1007/s00330-010-2045-7. Epub 2011 Jan 5.

DOI:10.1007/s00330-010-2045-7
PMID:21207035
Abstract

OBJECTIVES

In this retrospective study the success and complication rates after radiologically guided port catheter implantation were evaluated.

METHODS

Between 2000 and 2008, 3,160 port catheter systems were implanted in our interventional suite. All interventions were imaging guided. The puncture of the preferably right internal jugular vein (IJV) was ultrasound-assisted and the catheter tip position was controlled with fluoroscopy. Catheter indwelling time and rates of periprocedural, early and late complications were evaluated.

RESULTS

922,599 catheter days (mean, 292 days; range, 0-2,704 days) were documented. The implantation was successful in 3,153 (99.8%) cases. A total of 374 (11.8%; 0.41/1,000 catheter days) adverse events were recorded. Of these, 42 (1.33%) were periprocedural complications. 86 (3.3%; 0.09/1,000 catheter days) early and 246 (9.4%; 0.27/1,000 catheter days) late onset complications occurred after port implantation. The most common complications were blood stream infection (n = 134; 5.1%; 0.15/1,000 catheter days), catheter-induced venous thrombosis (n = 97; 3.7%; 0.11/1,000 catheter days) and catheter migration (n = 34; 1.3%; 0.04/1,000 catheter days). A total of 193 (6.1%) port explantations were required.

CONCLUSION

Ultrasound guided port implantation via the IJV results in low periprocedural complication rates.

摘要

目的

在这项回顾性研究中,评估了放射引导下端口导管植入的成功率和并发症发生率。

方法

在 2000 年至 2008 年间,我们的介入套房共植入了 3160 个端口导管系统。所有干预措施均为影像学引导。首选右侧颈内静脉(IJV)的穿刺采用超声辅助,导管尖端位置采用透视控制。评估导管留置时间以及围手术期、早期和晚期并发症的发生率。

结果

记录了 922599 个导管日(平均 292 天;范围 0-2704 天)。3153 例(99.8%)植入成功。共记录了 374 例(11.8%;0.41/1000 导管日)不良事件。其中 42 例(1.33%)为围手术期并发症。86 例(3.3%;0.09/1000 导管日)和 246 例(9.4%;0.27/1000 导管日)发生在端口植入后早期和晚期并发症。最常见的并发症是血流感染(n=134;5.1%;0.15/1000 导管日)、导管引起的静脉血栓形成(n=97;3.7%;0.11/1000 导管日)和导管迁移(n=34;1.3%;0.04/1000 导管日)。共需要进行 193 例(6.1%)端口取出术。

结论

经 IJV 超声引导的端口植入术可导致较低的围手术期并发症发生率。

相似文献

1
Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems.3160 例经放射引导植入完全植入式中央静脉港系统的结果分析。
Eur Radiol. 2011 Jun;21(6):1224-32. doi: 10.1007/s00330-010-2045-7. Epub 2011 Jan 5.
2
Combined ultrasound and fluoroscopy guided port catheter implantation--high success and low complication rate.超声与荧光透视联合引导下的端口导管植入术——高成功率和低并发症发生率。
Eur J Radiol. 2009 Mar;69(3):517-22. doi: 10.1016/j.ejrad.2007.10.018.
3
Ultrasound and fluoroscopy-guided placement of central venous ports via internal jugular vein: retrospective analysis of 1254 port implantations at a single center.超声和透视引导下经颈内静脉中央静脉置管:单中心 1254 例置管的回顾性分析。
Korean J Radiol. 2012 May-Jun;13(3):314-23. doi: 10.3348/kjr.2012.13.3.314. Epub 2012 Apr 17.
4
Evaluation of radiologically implanted central venous port systems explanted due to complications.对因并发症而取出的放射学植入式中心静脉导管系统的评估。
J Vasc Access. 2011 Oct-Dec;12(4):306-12. doi: 10.5301/JVA.2011.7739.
5
Letter to the Editor re: "Outcome analysis in 3160 implantations of radiologically guided placements of totally implantable central venous port systems": observations about right internal jugular access.
Eur Radiol. 2011 Oct;21(10):2166-7; author reply 2168. doi: 10.1007/s00330-011-2163-x. Epub 2011 May 28.
6
Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single-center experience of 316 cases.经头静脉行中心静脉置管,应用导管尖端位置的血管内电描记法进行控制:单中心 316 例经验。
World J Urol. 2012 Jun;30(3):399-404. doi: 10.1007/s00345-011-0752-6. Epub 2011 Aug 28.
7
[How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases].[泌尿外科医生应如何进行皮下中心静脉置管系统植入术?347例单中心经验]
Urologe A. 2012 Feb;51(2):226-37. doi: 10.1007/s00120-011-2715-3.
8
Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.经腋静脉置入全植入式静脉通路港用于头颈部恶性肿瘤患者的临床结局
J Vasc Access. 2019 Mar;20(2):134-139. doi: 10.1177/1129729818781270. Epub 2018 Jun 20.
9
[Surgical complications of totally implantable venous access port in children with malignant tumors].[完全植入式静脉输液港在儿童恶性肿瘤患者中的手术并发症]
Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Dec 18;54(6):1167-1171. doi: 10.19723/j.issn.1671-167X.2022.06.018.
10
Jugular versus subclavian totally implantable access ports: catheter position, complications and intrainterventional pain perception.颈静脉与锁骨下完全植入式输液港:导管位置、并发症和介入治疗中的疼痛感知。
Eur J Radiol. 2011 Sep;79(3):338-42. doi: 10.1016/j.ejrad.2009.12.010. Epub 2010 Mar 12.

引用本文的文献

1
A novel exploration of treating local skin infections around totally implantable venous access ports: port repositioning technique vs. port re-implantation technique.完全植入式静脉通路端口周围局部皮肤感染治疗的新探索:端口重新定位技术与端口重新植入技术对比
Eur J Med Res. 2025 Aug 13;30(1):747. doi: 10.1186/s40001-025-03039-8.
2
Comparison of outcomes for chemo-port implantation performed in the operating room and interventional radiology suite: a retrospective observational study.手术室与介入放射科进行化疗端口植入的结局比较:一项回顾性观察研究。
Ann Surg Treat Res. 2025 Jun;108(6):362-366. doi: 10.4174/astr.2025.108.6.362. Epub 2025 Jun 2.
3

本文引用的文献

1
Outcomes of surgical and radiologic placed implantable central venous access ports.外科和放射介入植入式中央静脉输液港的结果。
Am J Surg. 2009 Dec;198(6):829-33. doi: 10.1016/j.amjsurg.2009.04.031.
2
Analysis of risk factors for central venous port failure in cancer patients.癌症患者中心静脉置管失败的危险因素分析
World J Gastroenterol. 2009 Oct 7;15(37):4709-14. doi: 10.3748/wjg.15.4709.
3
Randomised comparison of complications from three different permanent central venous access systems.三种不同永久性中心静脉通路系统并发症的随机对照比较。
Early identification and rapid repositioning of a malpositioned infusion port catheter under real-time ultrasound guidance: A case report.
实时超声引导下对位置不当的输液港导管进行早期识别和快速重新定位:一例病例报告。
Medicine (Baltimore). 2025 Apr 18;104(16):e42126. doi: 10.1097/MD.0000000000042126.
4
Evaluating the Characteristics of the Totally Implantable Venous Access Device in Cancer Patients Using Fluorodeoxyglucose-PET/CT in the Absence of Suspected Catheter-Related Infections.在无疑似导管相关感染的情况下,使用氟脱氧葡萄糖-PET/CT评估癌症患者完全植入式静脉通路装置的特征。
Cureus. 2025 Feb 6;17(2):e78621. doi: 10.7759/cureus.78621. eCollection 2025 Feb.
5
The risk factors and prediction model for postoperative pneumonia after craniotomy.开颅术后肺炎的危险因素及预测模型
Front Cell Infect Microbiol. 2024 Dec 24;14:1375298. doi: 10.3389/fcimb.2024.1375298. eCollection 2024.
6
Evaluation of a novel central venous access port for direct catheter insertion without a peel-away sheath.一种无需剥离鞘即可直接插入导管的新型中心静脉通路端口的评估。
Jpn J Radiol. 2025 Feb;43(2):282-289. doi: 10.1007/s11604-024-01658-5. Epub 2024 Sep 17.
7
Vascular access devices for prolonged intravenous therapy regimens in people diagnosed with cancer.用于诊断患有癌症的患者进行长期静脉治疗方案的血管通路装置。
Cochrane Database Syst Rev. 2024 Aug 30;8(8):CD015667. doi: 10.1002/14651858.CD015667.
8
A Monocentric Analysis of Implantable Ports in Cancer Treatment: Five-Year Efficacy and Safety Evaluation.癌症治疗中植入式端口的单中心分析:五年疗效与安全性评估
Cancers (Basel). 2024 Aug 9;16(16):2802. doi: 10.3390/cancers16162802.
9
Technical Feasibility and Safety of Central Venous Ports for Intravenous Chemotherapy in Infants With Retinoblastoma: A Retrospective Study.视网膜母细胞瘤患儿静脉化疗中中心静脉港的技术可行性与安全性:一项回顾性研究
Cureus. 2024 Jan 13;16(1):e52231. doi: 10.7759/cureus.52231. eCollection 2024 Jan.
10
Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer.结直肠癌患者中心静脉置管后早期应用贝伐单抗的安全性
Cancers (Basel). 2023 Apr 12;15(8):2264. doi: 10.3390/cancers15082264.
Swiss Med Wkly. 2009 May 30;139(21-22):313-6. doi: 10.4414/smw.2009.12523.
4
Combined ultrasound and fluoroscopy guided port catheter implantation--high success and low complication rate.超声与荧光透视联合引导下的端口导管植入术——高成功率和低并发症发生率。
Eur J Radiol. 2009 Mar;69(3):517-22. doi: 10.1016/j.ejrad.2007.10.018.
5
Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial.成人癌症治疗患者预防导管相关并发症的中心静脉置管最佳部位选择:一项随机试验
Ann Oncol. 2009 May;20(5):935-40. doi: 10.1093/annonc/mdn701. Epub 2009 Jan 29.
6
Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.与实体瘤患者相比,血液系统恶性肿瘤的年轻患者发生感染性端口并发症的情况更为常见。
Oncology. 2008;74(3-4):237-44. doi: 10.1159/000151393. Epub 2008 Aug 21.
7
An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction.一项关于完全植入式中心静脉通路港的11年回顾性研究:并发症与患者满意度
Eur J Surg Oncol. 2009 Mar;35(3):241-6. doi: 10.1016/j.ejso.2008.01.020. Epub 2008 Mar 10.
8
Experience of anesthesiologists with percutaneous nonangiographic venous access.麻醉医生经皮非血管造影静脉穿刺置管的经验。
J Clin Anesth. 2007 Dec;19(8):609-15. doi: 10.1016/j.jclinane.2007.06.016.
9
Tip position of long-term central venous access devices used for parenteral nutrition.用于肠外营养的长期中心静脉通路装置的尖端位置
JPEN J Parenter Enteral Nutr. 2007 Sep-Oct;31(5):382-7. doi: 10.1177/0148607107031005382.
10
Which is the easiest and safest technique for central venous access? A retrospective survey of more than 5,400 cases.哪种是最简便且最安全的中心静脉置管技术?一项对5400多例病例的回顾性调查。
J Vasc Access. 2000 Jul-Sep;1(3):100-7. doi: 10.1177/112972980000100306.